β-Adrenergic Agonists for Preterm Labor
- 30 July 1992
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (5) , 349-351
- https://doi.org/10.1056/nejm199207303270510
Abstract
The infant mortality rate has become a benchmark in measuring progress toward U.S. health objectives. Approximately 40,000 infants die in the United States each year before reaching their first birthday. The overwhelming risk factor for infant mortality is low birth weight; indeed, two thirds of all infants who die before the age of one year weigh less than 2500 g at birth.1 During the 1980s there was a steady increase in the incidence of preterm delivery,2 the most important cause of low birth weight. Clearly, national strategies aimed at reducing infant mortality must include efforts to prevent preterm birth.On . . .Keywords
This publication has 7 references indexed in Scilit:
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist RitodrineNew England Journal of Medicine, 1992
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOURThe Lancet, 1986
- Development of Tolerance to the Metabolic Actions of β2‐Adrenoceptor Stimulating DrugsActa Obstetricia et Gynecologica Scandinavica, 1982
- Is the Relaxing Effect of β‐Adrenergic Agonists on the Human Myometrium only Transitory?Acta Obstetricia et Gynecologica Scandinavica, 1982
- Ritodrine Release Criticized and DefendedNew England Journal of Medicine, 1981
- Results of Double-blind, Multicentre Study with Ritodrine in Premature LabourBMJ, 1971